Milestone Scientific Files 8-K

TL;DR

MSNI filed an 8-K on 12/20 for events on 12/18. Standard update.

AI Summary

Milestone Scientific Inc. filed an 8-K on December 20, 2024, reporting other events and financial statements as of December 18, 2024. The filing details the company's corporate structure and operational information, including its principal executive offices located at 425 Eagle Rock Avenue, Suite 403, Roseland, NJ 07068.

Why It Matters

This 8-K filing provides an update on Milestone Scientific Inc.'s corporate and financial reporting, which is crucial for investors to stay informed about the company's status.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting corporate and financial information, not indicating any immediate significant risks or changes.

Key Players & Entities

• MILESTONE SCIENTIFIC INC. (company) — Registrant
• December 18, 2024 (date) — Date of earliest event reported
• December 20, 2024 (date) — Filing date
• Delaware (jurisdiction) — State of Incorporation
• 425 Eagle Rock Avenue Suite 403 Roseland , NJ 07068 (address) — Address of principal executive offices
• 973 - 535-2717 (phone_number) — Registrant's phone number

FAQ

Key Financial Figures

• $350,000 — ll be paid an annual fee at the rate of $350,000, at the at the rate of $150,000 in resp
• $150,000 — rate of $350,000, at the at the rate of $150,000 in respect of the first calendar quarte
• $66,666 — dar quarter of 2025, and at the rate of $66,666, in respect of each subsequent calendar

Filing Documents

• mlss20241219_8k.htm (8-K) — 30KB
• ex_759202.htm (EX-10.1) — 8KB
• a01.jpg (GRAPHIC) — 279KB
• a02.jpg (GRAPHIC) — 329KB
• a03.jpg (GRAPHIC) — 354KB
• a04.jpg (GRAPHIC) — 240KB
• a05.jpg (GRAPHIC) — 235KB
• a06.jpg (GRAPHIC) — 78KB
• a07.jpg (GRAPHIC) — 86KB
• a08.jpg (GRAPHIC) — 312KB
• a09.jpg (GRAPHIC) — 364KB
• a10.jpg (GRAPHIC) — 345KB
• a11.jpg (GRAPHIC) — 120KB
• a12.jpg (GRAPHIC) — 72KB
• 0001437749-24-038111.txt ( ) — 4042KB
• mlss-20241218.xsd (EX-101.SCH) — 3KB
• mlss-20241218_def.xml (EX-101.DEF) — 11KB
• mlss-20241218_lab.xml (EX-101.LAB) — 15KB
• mlss-20241218_pre.xml (EX-101.PRE) — 11KB
• mlss20241219_8k_htm.xml (XML) — 3KB

01 Other Events

Item 8.01 Other Events . Milestone Scientific Inc. (the "Company") previously announced that Mr. Arjan Haverhals, the Chief Executive Officer of the Company, would continue as a director and, beginning in January 1, 2025, would become a consultant to the Company. On December 18, 2024, the Company concluded a consulting agreement (the "Consulting Agreement") with Mr. Haverhals, through his consulting company, RH Consulting LLC. The Consulting Agreement provides that Mr. Haverhals will be available to provide the following services: (i) assistance and guidance on sales and business strategies for both the dental and medical business, including quarterly sales forecast;( ii) support of and interaction with the medical team on reimbursement strategies and distributor management; (iii) support and interaction with the dental team on sales growth and international expansion; (iv) assist in international medical business expansion; (v) input and guidance on marketing and educational strategies; and (vi) soundboard for R&D projects. There are no minimum time requirements for the provision of the services or Mr. Haverhals' availability. The provision of services under the Consulting Agreement will commence on January 1, 2025, and continue for an indefinite period, subject to the Company having the right to terminate the Consulting Agreement on 30 days advance notice in the event of his disability to provide services and either party having the right to terminate the Consulting Agreement on 90 days' advance notice. Mr. Haverhals will be paid an annual fee at the rate of $350,000, at the at the rate of $150,000 in respect of the first calendar quarter of 2025, and at the rate of $66,666, in respect of each subsequent calendar quarter of 2025, payable monthly in arrears, in each case in equal monthly installments on the last day of each month of such quarter. The Company will reimburse Mr. Haverhals for reasonable expenses in providing the services. Mr. Haverhals will be an

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit 10.1 Form of Consulting Agreement between RH Consulting LLC and Milestone Scientific Inc. dated December 18, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MILESTONE SCIENTIFIC INC. Dated: December 20, 2024 /s/ Arjan Haverhals Arjan Haverhals, Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR